Skip to main content
Caplight Logo









Avotres Inc.

Avotres Inc.

Private
New JerseyHealthcare & Life Scienceshttps://www.avotres.com/

Last Round

Series A

Feb 24, 2021

Total Funding Raised

$4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Avotres Inc. is a biotechnology company that develops novel immune-regulating therapies for autoimmune diseases, cancers, and transplantation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologycell therapyautoimmune diseasebiotechimmunologyautologous therapymonoclonal antibodytherapeutic developmentdiagnostic assayimmuno-oncologyclinical trialsdrug discoveryprecision medicinebiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avotres Inc. Comparables

Compare Avotres Inc. with similar companies based on industry and business-model similarity.

Avotres Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mozart Therapeutics
88%
GentiBio
84%
Tr1X
84%

Avotres Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 24, 2021

Avotres Inc. Investors

Notable investors and investment history

Avotres Inc. investors
InvestorRounds
Photon FundSeries A
Foothill VenturesSeries A
Proxima Ventures Ltd.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 109% MoM, reaching 4.1K.

  • Jul 25, 2026

    Monthly visitors increased 159% MoM, reaching 1.9K.

Avotres Inc. Filings

Explore SEC and related filing metadata, where available.

Avotres Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Avotres Inc.'s valuation, stock price, and market status.

Is Avotres Inc. a public or private company?

Avotres Inc. is a private company.

What is the current stock price of Avotres Inc.?

Avotres Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Avotres Inc. worth (valuation)?

Valuation information for Avotres Inc. is not publicly available.

Can I buy Avotres Inc. stock?

Avotres Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Avotres Inc.'s last funding round?

Avotres Inc.'s most recent funding round was Series A on February 24, 2021.

Who are the main investors in Avotres Inc.?

Key investors in Avotres Inc. include Photon Fund, Foothill Ventures, Proxima Ventures Ltd..

Will Avotres Inc. IPO soon?

No public IPO plans have been announced for Avotres Inc..

How can I track Avotres Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avotres Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew Jersey
Employee Range4
Year Founded2017
Last FundingFeb 24, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?